Chile looks at non-AUGE coverage:
This article was originally published in Clinica
Executive Summary
Chile has expressed general satisfaction at the results of an assessment of the quality of primary and secondary care services not covered by the AUGE "explicit healthcare guarantees" programme, but acknowledges that some areas will need improving. Low rates of cervical smear (Pap) screening and apparent deficiencies in the care of diabetes and hypertension are a source of concern, said the government's subsecretary of healthcare networks, Ricardo Fabrega. In addition, progress in providing hip replacement surgery (in age groups exempt from AUGE) had "slightly levelled out", he said. Despite this, "the results of this study refute suggestions that Plan AUGE would result in deficiencies in areas of care that are not yet included in the programme," said Mr Fabrega.
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.